An Interest In:
Web News this Week
- March 2, 2024
- March 1, 2024
- February 29, 2024
- February 28, 2024
- February 27, 2024
- February 26, 2024
- February 25, 2024
April 13, 2020 07:15 pm
Photo by Adisorn Chabsungnoen / SOPA Images / LightRocket via Getty Images
Original Link: https://www.theverge.com/2020/4/13/21216513/plasma-blood-coronavirus-treament-drug-development-antibodies
Why were still relying on a century-old strategy to treat COVID-19
Photo by Adisorn Chabsungnoen / SOPA Images / LightRocket via Getty Images
COVID-19 research is advancing at an unprecedented speed, but one strategy doctors are leaning on to treat COVID-19 patients looks more antiquated than innovative. In hospitals around the United States, caregivers are resorting to using century-old convalescent plasma therapy — siphoning blood from survivors and reinfusing it into the sick.
That’s because the hundreds of research papers published in the past few months and the record-setting leaps in vaccine development haven’t been fast enough to keep up with the blistering speed of the ongoing pandemic. People are sick and dying now, which is why doctors are falling back on plasma therapy as one stopgap measure that they hope can help in the lag time before other treatments come...
Original Link: https://www.theverge.com/2020/4/13/21216513/plasma-blood-coronavirus-treament-drug-development-antibodies
Share this article:
Tweet
View Full Article
The Verge
The Verge is an ambitious multimedia effort founded in 2011More About this Source Visit The Verge